Home
About
Overview
Sharing Data
ORCID
Help
History (56)
Smoking and inflammatory bowel disease.
Analysis and visualization of Arabidopsis thaliana GWAS using web 2.0 technologies.
The Holy Grail, or only half way there?
Advances in the management of Crohn's disease: economic and clinical potential of infliximab.
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
See All 56 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis. Gut. 1999 Apr; 44(4):455.
View in:
PubMed
subject areas
Acute Disease
Aminosalicylic Acids
Anti-Inflammatory Agents, Non-Steroidal
Colitis, Ulcerative
Female
Humans
Male
Mesalamine
Phenylhydrazines
Randomized Controlled Trials as Topic
authors with profiles
Stephen B. Hanauer